Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build Kenya flag

Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

: Kenya Radiotherapy Intent Code System

Active as of 2026-06-04

Raw xml | Download


<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="rt-intent-cs"/>
  <language value="en"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem rt-intent-cs</b></p><a name="rt-intent-cs"> </a><a name="hcrt-intent-cs"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/fhir/CodeSystem/rt-intent-cs</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">CURATIVE<a name="rt-intent-cs-CURATIVE"> </a></td><td>Curative</td><td>Radical RT aimed at cure or complete local control.</td></tr><tr><td style="white-space:nowrap">PALLIATIVE<a name="rt-intent-cs-PALLIATIVE"> </a></td><td>Palliative</td><td>RT to relieve symptoms (pain, bleeding, obstruction).</td></tr><tr><td style="white-space:nowrap">ADJUVANT<a name="rt-intent-cs-ADJUVANT"> </a></td><td>Adjuvant</td><td>RT given after surgery to reduce local recurrence risk.</td></tr><tr><td style="white-space:nowrap">NEO-ADJUVANT<a name="rt-intent-cs-NEO-ADJUVANT"> </a></td><td>Neo-adjuvant</td><td>Pre-operative RT to downstage the tumour.</td></tr><tr><td style="white-space:nowrap">PROPHYLACTIC<a name="rt-intent-cs-PROPHYLACTIC"> </a></td><td>Prophylactic</td><td>RT to prevent disease at a site of potential spread.</td></tr><tr><td style="white-space:nowrap">SALVAGE<a name="rt-intent-cs-SALVAGE"> </a></td><td>Salvage</td><td>RT for recurrent disease after prior local treatment.</td></tr><tr><td style="white-space:nowrap">STEREOTACTIC<a name="rt-intent-cs-STEREOTACTIC"> </a></td><td>Stereotactic (SRS/SBRT)</td><td>High-precision single or few-fraction RT.</td></tr><tr><td style="white-space:nowrap">RADIOSURGERY<a name="rt-intent-cs-RADIOSURGERY"> </a></td><td>Radiosurgery</td><td>Single-fraction stereotactic treatment.</td></tr><tr><td style="white-space:nowrap">CONCURRENT-CRT<a name="rt-intent-cs-CONCURRENT-CRT"> </a></td><td>Concurrent Chemo-RT</td><td>RT given concurrently with chemotherapy.</td></tr></table></div>
  </text>
  <url value="https://nshr-uat.sha.go.ke/fhir/CodeSystem/rt-intent-cs"/>
  <version value="0.1.0"/>
  <name value="RTIntentCS"/>
  <title value="Kenya Radiotherapy Intent Code System"/>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2026-06-04T14:49:30+00:00"/>
  <publisher value="Digital Health Agency (DHA), Kenya"/>
  <contact>
    <name value="Digital Health Agency (DHA), Kenya"/>
    <telecom>
      <system value="url"/>
      <value value="https://dha.go.ke"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="info@dha.go.ke"/>
    </telecom>
  </contact>
  <contact>
    <name value="Digital Health Agency Kenya – FHIR Team"/>
    <telecom>
      <system value="email"/>
      <value value="info@dha.go.ke"/>
      <use value="work"/>
    </telecom>
    <telecom>
      <system value="url"/>
      <value value="https://dha.go.ke"/>
      <use value="work"/>
    </telecom>
  </contact>
  <description
               value="Codes for the clinical intent of a radiotherapy treatment course."/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="KE"/>
      <display value="Kenya"/>
    </coding>
  </jurisdiction>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="9"/>
  <concept>
    <code value="CURATIVE"/>
    <display value="Curative"/>
    <definition value="Radical RT aimed at cure or complete local control."/>
  </concept>
  <concept>
    <code value="PALLIATIVE"/>
    <display value="Palliative"/>
    <definition
                value="RT to relieve symptoms (pain, bleeding, obstruction)."/>
  </concept>
  <concept>
    <code value="ADJUVANT"/>
    <display value="Adjuvant"/>
    <definition
                value="RT given after surgery to reduce local recurrence risk."/>
  </concept>
  <concept>
    <code value="NEO-ADJUVANT"/>
    <display value="Neo-adjuvant"/>
    <definition value="Pre-operative RT to downstage the tumour."/>
  </concept>
  <concept>
    <code value="PROPHYLACTIC"/>
    <display value="Prophylactic"/>
    <definition value="RT to prevent disease at a site of potential spread."/>
  </concept>
  <concept>
    <code value="SALVAGE"/>
    <display value="Salvage"/>
    <definition
                value="RT for recurrent disease after prior local treatment."/>
  </concept>
  <concept>
    <code value="STEREOTACTIC"/>
    <display value="Stereotactic (SRS/SBRT)"/>
    <definition value="High-precision single or few-fraction RT."/>
  </concept>
  <concept>
    <code value="RADIOSURGERY"/>
    <display value="Radiosurgery"/>
    <definition value="Single-fraction stereotactic treatment."/>
  </concept>
  <concept>
    <code value="CONCURRENT-CRT"/>
    <display value="Concurrent Chemo-RT"/>
    <definition value="RT given concurrently with chemotherapy."/>
  </concept>
</CodeSystem>